Picture of Vext Science logo

VEXT Vext Science Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
C2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4.9910.94.4-22.4-18
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items3.31-0.233-13.68.647.24
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1.74-7.187.040.5938.27
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities11.75.724.423.2911.7
Capital Expenditures-18.8-8.86-2.74-1.47-3.57
Purchase of Fixed Assets
Other Investing Cash Flow Items-8.31-21.5-2.09-3.97-2.09
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-27.1-30.3-4.82-5.44-5.66
Financing Cash Flow Items-1.5-1.63-1.03-1.74
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities20.124.13.19-1.95-5.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.72-0.5332.79-4.10.458